Welcome to Shanghai Probechem Biochemicals Co Ltd !Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : Ebronucimab
Catalog No.: PC-38817Not For Human Use, Lab Use Only.
Ebronucimab (AK109) is a monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) with potential for the treatment of primary hyperlipidemias, including homozygous familial hypercholesterolemia (HoFH), heterozygous familial hypercholesterolemia (HeFH) and other primary hypercholesterolemia.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 1 mg | Get quote | ||
| 5 mg | Get quote | ||
| 10 mg | Get quote | ||
| 25 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Ebronucimab (AK109) is a monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) with potential for the treatment of primary hyperlipidemias, including homozygous familial hypercholesterolemia (HoFH), heterozygous familial hypercholesterolemia (HeFH) and other primary hypercholesterolemia.
Isotype: IgG1-lambda2.
Anti-[human PCSK9 (proprotein convertase subtilisin/kexin type 9, neural apoptosis-regulated convertase 1, NARC1,
NARC-1, proprotein convertase 9, PC9)], human monoclonal antibody.
| M.Wt | ||
| Formula | ||
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
